[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-279968-105":53,"doc-detail-279968-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","mayday-fund-annual-report-2018-trustee-letter","Mayday Fund Annual Report 2018 - Trustee Letter","","Trustee Letter for the Mayday Fund Annual Report 2018, highlighting the Fund’s mission to answer a “mayday call” around pain by supporting responsible research, clinical care strategies, and professional networking. It addresses the scale of chronic pain and the limitations of available tools, describing 2018 initiatives focused on biomarkers, non-opioid chronic pain management models, and pain care networks across institutions. It also covers pediatric pain efforts using apps and virtual reality, work on core outcomes for persistent pain trials, and strategies for patients with communication impairments.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":41,"@type":70,"position":76},"https://docshare.wps.com/template/letters/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/mayday-fund-annual-report-2018-trustee-letter/279968/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/mayday-fund-annual-report-2018-trustee-letter/279968.png","ImageObject",442,249,{"name":88,"@type":89},"Theodora","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-30","2026-09-16",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",6,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What challenge does the Trustee Letter describe about pain research and treatment tools?","Question",{"text":109,"@type":110},"It emphasizes that the prevalence of pain is great while the tools needed to address pain are limited, creating an urgent need for evidence and practical strategies.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"Which major themes and targets guide the Fund’s projects in 2018?",{"text":114,"@type":110},"Key targets include biomarkers to identify pain signatures and projects that develop evidence-based treatments across acute and chronic pain, including pain throughout the life-span.",{"name":116,"@type":107,"acceptedAnswer":117},"How does the Fund approach pediatric pain in 2018?",{"text":118,"@type":110},"It supports clinical care projects using an app, virtual reality, and distraction therapies, and it works on core outcomes for persistent pediatric pain to improve pediatric clinical trial standards.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},279968,1791378604,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":40,"category_name":41,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":73,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":9},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","The Mayday Fund Annual Report 2018  \nMay 1, 2019  \nTrustee Letter  \nThe Mayday Fund logo, Morse code for SOS written in dots and dashes, has served the Fund well. To send a ‘mayday’ is to acknowledge danger and risk. The fields of pain research and medicine face the challenge that the prevalence of pain is great. In 2016 according to the Centers for Disease Control and Prevention, as many as 20.4% of adult Americans experienced chronic pain and 8% experienced high impact chronic pain. 1 At the same time, the tools needed to address pain are limited. In response to this‘mayday call,’ it has been the work of The Mayday Fund to responsibly support research, clinical care strategies and networking to provide tools and evidence that pain might be treated and eased.  \nIn 2018 and continuing into 2019, the discourse on pain in the United States and in many other countries has been dominated by the Opioid Crisis and the ravages it has created. With this as a backdrop, the Fund sought projects that have the potential to discover both what pain is and how it works, as well as to aid in the development of evidence-based treatments that respond to real world clinical care of pain, both acute and chronic. Additionally, The Mayday Fund has continued to seek projects that cover pain across the life-span, from the neonate to the geriatric patient.  \nOne target for the Fund has been ‘biomarkers,’ evidence that there is a signature for pain that can be identified, visualized and potentially corrected. In the last several years, the Fund has supported research in both biochemistry and neuroimaging as ways to advance this evidence. Among the projects supported in 2018 was one on the use of the cornea as a site to diagnose pain and another to clinically evaluate newly identified biomarkers that expedite treatment of multiple chronic pain conditions. A theme running through this work is how to better address the needs of those in chronic pain, a condition/disease that is both complex and mysterious.  \nAnother target is to increase the body of knowledge about pain that might be used responsibly by scientists, clinicians and caregivers. The Fund contributed to two Lancet Commissions on Palliative Care and Pain Control (published in 2018) and on Pediatric Pain Support (in process) . It hosted a meeting on“Non-Opioid Management of Chronic Pain: Developing Value-Based Models,” at the Banbury Conference Center, where leaders explored strategies to better address how to support pain care as part of larger health care systems.  \nPursuant to the Trustees’ interests in creating networks to improve the quality of pain care, the Fund contributed to the National Academies of Science, Engineering and Medicine’s Roundtable on Serious Illnesses that focused on pain. And, to better serve the pain research community, the Fund continued its commitment to the ongoing work of the Pain Research Forum.2 At a more local level and to translate knowledge about pain into coordinated policies, the Fund made a grant to help create the Connecticut Pain Consortium. Led jointly by The University of Connecticut and the Jackson Laboratories, this initiative has the goal to create a network of public and private institutions to improve the quality of pain care across the State of Connecticut.  \nSince its creation in 1993, The Mayday Fund has been supportive of work done in the field of Pediatric Pain. In 2018, it funded several projects that address clinical care via the use of an app, Virtual Reality and distraction therapies. The Fund has convened a working group to develop “Core Outcomes for Persistent Pediatric Pain (COPPP)” to improve the standards of clinical trials involving children by revising what had become the gold standard for such trial design.3 To address the need to be certain that  \n1 [https://www.cdc.gov/mmwr/volumes/67/wr/mm6736a2.htm](https://www.cdc.gov/mmwr/volumes/67/wr/mm6736a2.htm)[ ](https://www.cdc.gov/mmwr/volumes/67/wr/mm6736a2.htm)[2](2 www.painresearch","cbCaioFQIhOhTFxQ","https://ap.wps.com/l/cbCaioFQIhOhTFxQ","pdf",126528,"English","# Trustee Letter\n## Pain burden and Mayday’s response\n## Focus on biomarkers and evidence-based treatments\n## Knowledge building through commissions and convenings\n## Building networks for serious illness and pain research","[{\"question\":\"What challenge does the Trustee Letter describe about pain research and treatment tools?\",\"answer\":\"It emphasizes that the prevalence of pain is great while the tools needed to address pain are limited, creating an urgent need for evidence and practical strategies.\"},{\"question\":\"Which major themes and targets guide the Fund’s projects in 2018?\",\"answer\":\"Key targets include biomarkers to identify pain signatures and projects that develop evidence-based treatments across acute and chronic pain, including pain throughout the life-span.\"},{\"question\":\"How does the Fund approach pediatric pain in 2018?\",\"answer\":\"It supports clinical care projects using an app, virtual reality, and distraction therapies, and it works on core outcomes for persistent pediatric pain to improve pediatric clinical trial standards.\"}]","Mayday Fund Annual Report 2018 - Trustee Letter | PDF",1789530737]